Skip Navigation


JAC Advance Access originally published online on March 2, 2005
Journal of Antimicrobial Chemotherapy 2005 55(4):420-423; doi:10.1093/jac/dki056
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
55/4/420    most recent
dki056v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Keller, M. J.
Right arrow Articles by Herold, B. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keller, M. J.
Right arrow Articles by Herold, B. C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions{at}oupjournals.org

Leading article

Topical microbicides for the prevention of genital herpes infection

Marla J. Keller1, Ana Tuyama2, Maria Josefina Carlucci2 and Betsy C. Herold2,*

Departments of 1 Medicine and 2 Pediatrics, Division of Infectious Diseases, Mount Sinai School of Medicine, New York, NY, USA

* Correspondence address. Division of Infectious Diseases, 1 Gustave L. Levy Place, Box 1090, New York, NY 10029, USA. Tel: +1-212-241-5272; Fax: +1-212-426-4813; Email: betsy.herold{at}mssm.edu

Genital herpes is one of the most prevalent sexually transmitted infections worldwide and is the most common cause of genital ulcers. Despite increased public awareness and the initiation of efforts to prevent transmission, the prevalence of herpes simplex virus (HSV) type 2 continues to increase. What makes HSV so difficult to control is that most sexual and perinatal transmission occurs during unrecognized or asymptomatic shedding. The impact of genital herpes as a public health threat is amplified because of its epidemiological synergy with HIV/AIDS. Thus, there is an urgent need for novel prophylactic methods, such as topical microbicides designed for genital application, to prevent both HSV and HIV transmission. Several candidate microbicides are being advanced to clinical trials based on in vitro activity and animal studies. These include compounds that inactivate virus directly, those that enhance innate immunity, and drugs that block viral binding and entry. A more vigorous evaluation of the safety of these and other candidate topical microbicides in development should include assessment of the impact of repeated application on innate host defences in the genital tract.

Keywords: HIV , HSV , innate immunity


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
D. Pinna, P. Oreste, T. Coradin, A. Kajaste-Rudnitski, S. Ghezzi, G. Zoppetti, A. Rotola, R. Argnani, G. Poli, R. Manservigi, et al.
Inhibition of Herpes Simplex Virus Types 1 and 2 In Vitro Infection by Sulfated Derivatives of Escherichia coli K5 Polysaccharide
Antimicrob. Agents Chemother., September 1, 2008; 52(9): 3078 - 3084.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
D. I. Bernstein, N. Goyette, R. Cardin, E. R. Kern, G. Boivin, J. Ireland, J.-M. Juteau, and A. Vaillant
Amphipathic DNA Polymers Exhibit Antiherpetic Activity In Vitro and In Vivo
Antimicrob. Agents Chemother., August 1, 2008; 52(8): 2727 - 2733.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
A. G. Artemenko, E. N. Muratov, V. E. Kuz'min, N. A. Kovdienko, A. I. Hromov, V. A. Makarov, O. B. Riabova, P. Wutzler, and M. Schmidtke
Identification of individual structural fragments of N,N'-(bis-5-nitropyrimidyl)dispirotripiperazine derivatives for cytotoxicity and antiherpetic activity allows the prediction of new highly active compounds
J. Antimicrob. Chemother., July 1, 2007; 60(1): 68 - 77.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Saidi, J. Eslaphazir, C. Carbonneil, L. Carthagena, M. Requena, N. Nassreddine, and L. Belec
Differential Modulation of Human Lactoferrin Activity against Both R5 and X4-HIV-1 Adsorption on Epithelial Cells and Dendritic Cells by Natural Antibodies
J. Immunol., October 15, 2006; 177(8): 5540 - 5549.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
K. C. Yim, C. J. Carroll, A. Tuyama, N. Cheshenko, M. J. Carlucci, D. D. Porter, G. A. Prince, and B. C. Herold
The Cotton Rat Provides a Novel Model To Study Genital Herpes Infection and To Evaluate Preventive Strategies
J. Virol., December 1, 2005; 79(23): 14632 - 14639.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. Cheshenko, W. Liu, L. M. Satlin, and B. C. Herold
Focal Adhesion Kinase Plays a Pivotal Role in Herpes Simplex Virus Entry
J. Biol. Chem., September 2, 2005; 280(35): 31116 - 31125.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.